Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42])

The summary for the Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42])
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-06-029
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 21, 2005
	Creation Date:	Oct 21, 2005
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Apr 14, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award for both Phase I and Phase II awards, meets all of the following criteria: - Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. - Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. - Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's (SBA) Government Contracting Area Office or Office of Size Standards.
Grant Description: - The purpose of this Funding Opportunity Announcement (FOA) is to solicit from NICHD-supported STTR Phase II awardees, competing continuation applications that propose to continue the process of assessing and improving devices or conducting preclinical studies of drugs or devices that ultimately require: 1) clinical evaluation, 2) approval of a Federal regulatory agency, and 3) continuing refinements to durable medical equipment (DME) designs such as cost reduction, testing for safety, durability, and reliability, and meeting or establishing standards. Such products include, but are not limited to, devices, drugs, vaccines, medical implants, etc. related to the mission of the NICHD. - Awards in response to this solicitation are expected to average in the range of $150,000 to $300,000 total costs per year for up to three years. - The anticipated number of awards will depend upon the scientific/technical merit of applications received and the availability of funds. - This FOA will utilize the Phase II Small Business Technology Transfer (STTR [R42]) grant mechanism and runs in parallel with a FOA of identical scientific intent, PA-06-030, that solicits applications under the Phase II Small Business Technology Transfer Research program (STTR [R42]) grant mechanisms.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-06-029.html http://grants.nih.gov/grants/guide/pa-files/PA-06-029.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION; • RELIGIOUS ORGANIZATIONS AND HIV